Cancer Risk in Hysterectomies That Use Power Morcellators
February 14th, 2017|
Thousands of women every year undergo a hysterectomy. Over the years, this procedure has become less and less invasive, reducing incision size and recovery time. One innovative technique involves the use of power morcellators to remove the patient’s uterus and uterine fibroids through a small incision. Although less invasive, this technique has come under scrutiny in recent years for its part in spreading slow-growing cancer cells throughout the abdominal cavity.
Power morcellators enable the surgeon to essentially slice the uterus into pieces and remove those pieces through a smaller incision than traditional hysterectomies. Although this generally makes the surgery less invasive, the multiple cuts within the abdominal cavity can spread liquidized cancer tissue. Patients with undetected uterine sarcoma—a type of cancer that includes uterine leiomyosarcoma (ULMS)—are especially at risk.
If you or someone you love underwent a laparoscopic hysterectomy and developed ULMS, abdominal cancer, or uterine cancer, we want to help. You may be eligible for compensation for medical bills, lost wages, and more. Call our defective medical device attorneys today for a free evaluation of your claim. We have more than 35 years of experience fighting for the rights of defective medical device victims, and we’re ready to put that experience to work for you.